Human Molecular Genetics, 2000, Vol. 9, No. 16 2383-2394
© 2000 Oxford University Press
Transcriptional regulation of Alzheimer’s disease genes: implications for susceptibility
Flanders Interuniversity Institute for Biotechnology (VIB), Born-Bunge Foundation (BBS), University of Antwerp (UIA), Department of Biochemistry, Universiteitsplein 1, B-2610 Antwerpen, Belgium
In recent years, important progress has been made in uncovering genes implicated in Alzheimer’s disease (AD). Three causal genes have been identified in which mutations cause familial presenile AD: the amyloid precursor protein gene and the presenilin 1 and 2 genes. Additionally, the 
4 allele of the apolipoprotein E gene was shown to be a major risk factor for AD. Despite the genetic heterogeneity, all of these genes work through a common mechanism, i.e. increasing the amount and deposition of the amyloid ß peptide (Aß) in brain triggering AD-related neuronal degeneration. Therefore, the levels of Aß and of the factors involved in its production and deposition are important in the neuropathogenesis of AD. Regulation of transcription of AD genes might therefore be an important player in the neurodegenerative process. In this review, we describe the major features of transcriptional regulation of the known AD genes and the implications of variable expression levels on susceptibility to AD.
+ To whom correspondence should be addressed. Tel: +32 3 8202601; Fax: +32 3 8202541; Email: cvbroeck@uia.ua.ac.be
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  L. Guyant-Marechal, A. Rovelet-Lecrux, L. Goumidi, E. Cousin, D. Hannequin, G. Raux, C. Penet, S. Ricard, S. Mace, P. Amouyel, et al. Variations in the APP gene promoter region and risk of Alzheimer disease Neurology, February 27, 2007; 68(9): 684 - 687. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Sleegers, N. Brouwers, I. Gijselinck, J. Theuns, D. Goossens, J. Wauters, J. Del-Favero, M. Cruts, C. M. v. Duijn, and C. V. Broeckhoven APP duplication is sufficient to cause early onset Alzheimer's dementia with cerebral amyloid angiopathy Brain, November 1, 2006; 129(11): 2977 - 2983. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Brouwers, K. Sleegers, S. Engelborghs, V. Bogaerts, S. Serneels, K. Kamali, E. Corsmit, E. D. Leenheir, J.-J. Martin, P. P. De Deyn, et al. Genetic risk and transcriptional variability of amyloid precursor protein in Alzheimer's disease Brain, November 1, 2006; 129(11): 2984 - 2991. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. A. Bellingham, D. K. Lahiri, B. Maloney, S. La Fontaine, G. Multhaup, and J. Camakaris Copper Depletion Down-regulates Expression of the Alzheimer's Disease Amyloid-{beta} Precursor Protein Gene J. Biol. Chem., May 7, 2004; 279(19): 20378 - 20386. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Theuns, J. Remacle, R. Killick, E. Corsmit, K.'l Vennekens, D. Huylebroeck, M. Cruts, and C. V. Broeckhoven Alzheimer-associated C allele of the promoter polymorphism -22C>T causes a critical neuron-specific decrease of presenilin 1 expression Hum. Mol. Genet., April 15, 2003; 12(8): 869 - 877. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. S. Athan, J. H. Lee, A. Arriaga, R. P. Mayeux, and B. Tycko Polymorphisms in the Promoter of the Human APP Gene: Functional Evaluation and Allele Frequencies in Alzheimer Disease Arch Neurol, November 1, 2002; 59(11): 1793 - 1799. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J.-C. Lambert, D. M A Mann, J. M Harris, M.-C. Chartier-Harlin, A. Cumming, J. Coates, H. Lemmon, D. StClair, T. Iwatsubo, and C. Lendon The {-}48 C/T polymorphism in the presenilin 1 promoter is associated with an increased risk of developing Alzheimer's disease and an increased A{beta} load in brain J. Med. Genet., June 1, 2001; 38(6): 353 - 355. [Abstract] [Full Text]
|
|